Clarus Group, Inc. Abb Vie Inc. Transaction History

Clarus Group, Inc.

$235 Million
Q3 2024

A detailed history of Clarus Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Clarus Group, Inc. holds 2,619 shares of ABBV stock, worth $459,320. This represents 0.22% of its overall portfolio holdings.

Number of Shares

2,619

Previous 2,752 4.83%

Holding current value

$459,320

Previous $472,000 9.53%

% of portfolio

0.22%

Previous 0.21%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$163.84 - $199.33 $21,790 - $26,510	-133 Reduced 4.83%	2,619 $517,000
Q2 2024 Jul 19, 2024	SELL	$154.79 - $180.76 $114,854 - $134,123	-742 Reduced 21.24%	2,752 $472,000
Q1 2024 Apr 22, 2024	BUY	$159.82 - $182.1 $1,118 - $1,274	7 Added 0.2%	3,494 $636,000
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $67,424 - $75,935	-490 Reduced 12.32%	3,487 $540,000
Q3 2023 Oct 16, 2023	SELL	$133.59 - $154.65 $35,935 - $41,600	-269 Reduced 6.34%	3,977 $592,000
Q2 2023 Jul 17, 2023	BUY	$132.51 - $164.9 $65,062 - $80,965	491 Added 13.08%	4,246 $572,000
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $15,328 - $17,653	106 Added 2.9%	3,755 $598,000
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $76,623 - $91,891	-554 Reduced 13.18%	3,649 $0
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $805 - $923	6 Added 0.14%	4,203 $564,000
Q2 2022 Jul 27, 2022	BUY	$137.62 - $174.96 $825 - $1,049	6 Added 0.14%	4,197 $643,000
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $12,142 - $15,065	-92 Reduced 2.15%	4,191 $679,000
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $859 - $1,087	8 Added 0.19%	4,283 $494,000
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $4,256 - $4,831	-40 Reduced 0.93%	4,275 $461,000
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $10,521 - $11,721	-100 Reduced 2.27%	4,315 $503,000
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $92.7 Million - $102 Million	-905,973 Reduced 99.52%	4,415 $465,000
Q1 2021 Apr 16, 2021	BUY	$102.3 - $112.62 $92.7 Million - $102 Million	906,538 Added 23546.44%	910,388 $7.32 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $309,886 - $418,379	3,850 New	3,850 $402,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarus Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clarus Group, Inc. with notifications on news.

Account